stockrowCME Group Inc.
CME Financial Financial Data & Stock Exchanges
CME Group Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.5 billion, up 6.37% from fiscal 2024.
- Revenue
- +13.0%
- EPS
- +16.5%
- Free cash flow
- +12.7%
- Total debt
- +0.11%
Quarter to September 2026, against a year earlier
Follow CME
Alert me
CME Group Inc. (CME) Shares outstanding
CME Group Inc.'s shares outstanding at the end of fiscal 2025 was $360.3M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $358.6M. Over the past ten years it has ranged from $337.9M (fiscal 2015) to $360.3M (fiscal 2025) — the current reading is the highest in ten years. CME Group Inc. ranks 3rd of 14 Financial Data & Stock Exchanges companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $360.3M | 0.10% |
| FY2024 | $359.9M | 0.12% |
| FY2023 | $359.5M | 0.09% |
| FY2022 | $359.2M | 0.07% |
| FY2021 | $358.9M | 0.11% |
| FY2020 | $358.5M | 0.08% |
| FY2019 | $358.2M | 4.22% |
| FY2018 | $343.7M | 1.03% |
| FY2017 | $340.2M | 0.37% |
| FY2016 | $339.0M | 0.32% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $358.6M | (0.73%) |
| Jun 2026 | $361.3M | (0.53%) |
| Mar 2026 | $363.2M | 0.80% |
| Dec 2025 | $360.3M | (0.03%) |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| NDAQ Nasdaq, Inc. compare | $563.3M |
| ICE Intercontinental Exchange Inc. compare | $563.0M |
| CME CME Group Inc. | $358.6M |
| SPGI S&P Global Inc. compare | $291.6M |
| COIN Coinbase Global, Inc. compare | $288.0M |
| TRU TransUnion compare | $192.6M |
| MCO Moody's Corporation compare | $173.3M |
| CBOE Cboe Global Markets, Inc. compare | $104.7M |
| MSCI MSCI Inc compare | $72.3M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on CME
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- The full statement